应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
MURA Mural Oncology
停牌 12-12 16:00:00 EST
2.04
+0.00
0.00%
最高
2.04
最低
2.04
成交量
0.00
今开
2.04
昨收
2.04
日振幅
0.00%
总市值
3,538万
流通市值
2,864万
总股本
1,734万
成交额
0.00
换手率
0.00%
流通股本
1,404万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Mural Oncology Plc2025财年第二财季实现净利润-47.98百万美元,同比减少52.03%
市场透视 · 08-10
Mural Oncology Plc2025财年第二财季实现净利润-47.98百万美元,同比减少52.03%
Mural Oncology Plc盘中异动 下午盘急速跳水5.06%报1.69美元
市场透视 · 08-08
Mural Oncology Plc盘中异动 下午盘急速跳水5.06%报1.69美元
Mural Oncology Plc盘中异动 快速下跌6.49%报1.73美元
市场透视 · 08-05
Mural Oncology Plc盘中异动 快速下跌6.49%报1.73美元
Mural Oncology Plc盘中异动 早盘大幅跳水5.17%报2.20美元
市场透视 · 08-04
Mural Oncology Plc盘中异动 早盘大幅跳水5.17%报2.20美元
Mural Oncology Plc盘中异动 股价大涨5.33%
市场透视 · 08-02
Mural Oncology Plc盘中异动 股价大涨5.33%
Mural Oncology Plc盘中异动 股价大涨5.36%
市场透视 · 07-15
Mural Oncology Plc盘中异动 股价大涨5.36%
Mural Oncology Plc盘中异动 下午盘股价大跌5.01%报2.45美元
市场透视 · 07-08
Mural Oncology Plc盘中异动 下午盘股价大跌5.01%报2.45美元
Mural Oncology Plc盘中异动 大幅拉升7.83%
市场透视 · 03-05
Mural Oncology Plc盘中异动 大幅拉升7.83%
Mural Oncology Plc盘中异动 快速下挫5.57%报3.48美元
市场透视 · 03-04
Mural Oncology Plc盘中异动 快速下挫5.57%报3.48美元
Mural Oncology Plc盘中异动 临近午盘大幅下挫5.18%
市场透视 · 02-26
Mural Oncology Plc盘中异动 临近午盘大幅下挫5.18%
Mural Oncology Plc盘中异动 股价大跌5.19%报3.84美元
市场透视 · 02-24
Mural Oncology Plc盘中异动 股价大跌5.19%报3.84美元
Mural Oncology Plc盘中异动 临近午盘股价大跌5.59%
市场透视 · 02-11
Mural Oncology Plc盘中异动 临近午盘股价大跌5.59%
Mural Oncology Plc盘中异动 急速上涨6.07%
市场透视 · 02-07
Mural Oncology Plc盘中异动 急速上涨6.07%
Mural Oncology Plc盘中异动 临近午盘股价大涨5.14%
市场透视 · 02-07
Mural Oncology Plc盘中异动 临近午盘股价大涨5.14%
Mural Oncology Plc盘中异动 早盘急速拉升5.15%
市场透视 · 02-05
Mural Oncology Plc盘中异动 早盘急速拉升5.15%
Mural Oncology(MURA.US)获Jones Trading首次覆盖,给予买入评级, 目标价16.00美元。
金融界 · 01-27
Mural Oncology(MURA.US)获Jones Trading首次覆盖,给予买入评级, 目标价16.00美元。
Mural Oncology Plc盘中异动 早盘快速下挫5.07%
市场透视 · 01-22
Mural Oncology Plc盘中异动 早盘快速下挫5.07%
Mural Oncology Plc盘中异动 股价大涨5.42%
市场透视 · 01-18
Mural Oncology Plc盘中异动 股价大涨5.42%
Mural Oncology Plc盘中异动 急速上涨5.89%报3.87美元
市场透视 · 01-10
Mural Oncology Plc盘中异动 急速上涨5.89%报3.87美元
Mural Oncology Plc盘中异动 股价大涨5.33%报3.66美元
市场透视 · 01-09
Mural Oncology Plc盘中异动 股价大涨5.33%报3.66美元
加载更多
公司概况
公司名称:
Mural Oncology
所属市场:
NASDAQ
上市日期:
--
主营业务:
Mural Oncology plc是一家爱尔兰注册公众有限公司,于2017年5月成立,是一家私人股份有限公司,2023年8月21日,该公司重新注册为公共有限公司,并更名为Mural Oncology plc。该公司是一家临床阶段的肿瘤学公司,专注于发现和开发可能有意义地改善癌症患者生活的免疫疗法。通过利用公司在免疫细胞调节和蛋白质工程方面的核心竞争力,该公司开发了一系列新型的研究性细胞因子疗法,旨在解决多种癌症患者未满足需求的领域。该公司的主要候选产品nemvaleukin alfa(“nemvaleukin”)是一种研究性、工程化的白细胞介素-2(“IL-2”)细胞因子,旨在捕获和扩大大剂量重组人IL-2(“rhIL-2”)的治疗益处,同时减轻其标志性毒性。
发行价格:
--
{"stockData":{"symbol":"MURA","market":"US","secType":"STK","nameCN":"Mural Oncology","latestPrice":2.04,"timestamp":1765573200000,"preClose":2.04,"halted":3,"volume":0,"delay":0,"floatShares":14041645,"shares":17344486,"eps":-6.925897,"marketStatus":"停牌","change":0,"latestTime":"12-12 16:00:00 EST","open":2.04,"high":2.04,"low":2.04,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-6.925897,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1765789200000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":2.04,"volumeRatio":0},"requestUrl":"/m/hq/s/MURA","defaultTab":"news","newsList":[{"id":"2558021975","title":"Mural Oncology Plc2025财年第二财季实现净利润-47.98百万美元,同比减少52.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2558021975","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558021975?lang=zh_cn&edition=full","pubTime":"2025-08-10 00:01","pubTimestamp":1754755296,"startTime":"0","endTime":"0","summary":"8月10日,Mural Oncology Plc公布财报,公告显示公司2025财年第二财季净利润为-47.98百万美元,同比减少52.03%;其中营业收入为0.00美元,每股基本收益为-2.78美元。从资产负债表来看,Mural Oncology Plc总负债28.77百万美元,其中短期债务5.01百万美元,资产负债比为3.05,流动比率为2.87。机构评级:截至2025年8月10日,当前有1家机构对Mural Oncology Plc目标价做出预测,其中目标均价为6.00美元,其中最低目标价为6.00美元,最高目标价为6.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250810000335a6dcb85c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250810000335a6dcb85c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MURA"],"gpt_icon":0},{"id":"2557598974","title":"Mural Oncology Plc盘中异动 下午盘急速跳水5.06%报1.69美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557598974","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557598974?lang=zh_cn&edition=full","pubTime":"2025-08-08 01:38","pubTimestamp":1754588313,"startTime":"0","endTime":"0","summary":"北京时间2025年08月08日01时38分,Mural Oncology Plc股票出现波动,股价急速下挫5.06%。截至发稿,该股报1.69美元/股,成交量17.5013万股,换手率1.01%,振幅5.77%。Mural Oncology Plc股票所在的生物技术行业中,整体跌幅为0.27%。Mural Oncology Plc公司简介:Mural Oncology PLC 是一家临床阶段的肿瘤公司,其整个业务都集中在发现和开发可能有意义地改善癌症患者生活的免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808013833973a0d5a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808013833973a0d5a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MURA"],"gpt_icon":0},{"id":"2557397524","title":"Mural Oncology Plc盘中异动 快速下跌6.49%报1.73美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557397524","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557397524?lang=zh_cn&edition=full","pubTime":"2025-08-05 21:50","pubTimestamp":1754401806,"startTime":"0","endTime":"0","summary":"北京时间2025年08月05日21时50分,Mural Oncology Plc股票出现异动,股价急速下跌6.49%。截至发稿,该股报1.73美元/股,成交量6.9464万股,换手率0.40%,振幅5.41%。Mural Oncology Plc股票所在的生物技术行业中,整体跌幅为3.08%。Mural Oncology Plc公司简介:Mural Oncology PLC 是一家临床阶段的肿瘤公司,其整个业务都集中在发现和开发可能有意义地改善癌症患者生活的免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080521500794d167fd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080521500794d167fd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MURA","BK4139"],"gpt_icon":0},{"id":"2556913387","title":"Mural Oncology Plc盘中异动 早盘大幅跳水5.17%报2.20美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2556913387","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556913387?lang=zh_cn&edition=full","pubTime":"2025-08-04 21:39","pubTimestamp":1754314761,"startTime":"0","endTime":"0","summary":"北京时间2025年08月04日21时39分,Mural Oncology Plc股票出现波动,股价大幅跳水5.17%。截至发稿,该股报2.20美元/股,成交量6.4264万股,换手率0.37%,振幅2.59%。Mural Oncology Plc股票所在的生物技术行业中,整体涨幅为0.84%。Mural Oncology Plc公司简介:Mural Oncology PLC 是一家临床阶段的肿瘤公司,其整个业务都集中在发现和开发可能有意义地改善癌症患者生活的免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508042139219732f414&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508042139219732f414&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MURA","BK4139"],"gpt_icon":0},{"id":"2556810913","title":"Mural Oncology Plc盘中异动 股价大涨5.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2556810913","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556810913?lang=zh_cn&edition=full","pubTime":"2025-08-02 00:29","pubTimestamp":1754065788,"startTime":"0","endTime":"0","summary":"北京时间2025年08月02日00时29分,Mural Oncology Plc股票出现波动,股价大幅拉升5.33%。截至发稿,该股报2.37美元/股,成交量11.7888万股,换手率0.68%,振幅3.56%。Mural Oncology Plc股票所在的生物技术行业中,整体涨幅为0.43%。Mural Oncology Plc公司简介:Mural Oncology PLC 是一家临床阶段的肿瘤公司,其整个业务都集中在发现和开发可能有意义地改善癌症患者生活的免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250802002948972d4b24&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250802002948972d4b24&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MURA","BK4139"],"gpt_icon":0},{"id":"2551138479","title":"Mural Oncology Plc盘中异动 股价大涨5.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2551138479","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551138479?lang=zh_cn&edition=full","pubTime":"2025-07-15 01:49","pubTimestamp":1752515360,"startTime":"0","endTime":"0","summary":"北京时间2025年07月15日01时49分,Mural Oncology Plc股票出现异动,股价急速拉升5.36%。Mural Oncology Plc股票所在的生物技术行业中,整体涨幅为0.68%。Mural Oncology Plc公司简介:Mural Oncology PLC 是一家临床阶段的肿瘤公司,其整个业务都集中在发现和开发可能有意义地改善癌症患者生活的免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715014920954262a2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715014920954262a2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MURA","BK4139"],"gpt_icon":0},{"id":"2549554343","title":"Mural Oncology Plc盘中异动 下午盘股价大跌5.01%报2.45美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2549554343","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549554343?lang=zh_cn&edition=full","pubTime":"2025-07-08 01:29","pubTimestamp":1751909381,"startTime":"0","endTime":"0","summary":"北京时间2025年07月08日01时29分,Mural Oncology Plc股票出现异动,股价急速跳水5.01%。截至发稿,该股报2.45美元/股,成交量3.2165万股,换手率0.19%,振幅4.26%。Mural Oncology Plc股票所在的生物技术行业中,整体跌幅为0.66%。Mural Oncology Plc公司简介:Mural Oncology PLC 是一家临床阶段的肿瘤公司,其整个业务都集中在发现和开发可能有意义地改善癌症患者生活的免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708012941a69b6207&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708012941a69b6207&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MURA","BK4139"],"gpt_icon":0},{"id":"2517436649","title":"Mural Oncology Plc盘中异动 大幅拉升7.83%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517436649","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517436649?lang=zh_cn&edition=full","pubTime":"2025-03-05 22:48","pubTimestamp":1741186088,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日22时48分,Mural Oncology Plc股票出现波动,股价快速拉升7.83%。截至发稿,该股报3.70美元/股,成交量1.5802万股,换手率0.09%,振幅3.97%。Mural Oncology Plc股票所在的生物技术行业中,整体涨幅为1.54%。Mural Oncology Plc公司简介:Mural Oncology PLC 是一家临床阶段的肿瘤公司,其整个业务都集中在发现和开发可能有意义地改善癌症患者生活的免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305224808963ae09e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305224808963ae09e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MURA","BK4139"],"gpt_icon":0},{"id":"2516128663","title":"Mural Oncology Plc盘中异动 快速下挫5.57%报3.48美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516128663","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516128663?lang=zh_cn&edition=full","pubTime":"2025-03-04 04:02","pubTimestamp":1741032148,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日04时02分,Mural Oncology Plc股票出现波动,股价大幅下挫5.57%。截至发稿,该股报3.48美元/股,成交量8.3909万股,换手率0.49%,振幅5.71%。Mural Oncology Plc股票所在的生物技术行业中,整体涨幅为0.20%。Mural Oncology Plc公司简介:Mural Oncology PLC 是一家临床阶段的肿瘤公司,其整个业务都集中在发现和开发可能有意义地改善癌症患者生活的免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304040229989a58d0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304040229989a58d0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MURA"],"gpt_icon":0},{"id":"2514117100","title":"Mural Oncology Plc盘中异动 临近午盘大幅下挫5.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514117100","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514117100?lang=zh_cn&edition=full","pubTime":"2025-02-26 00:39","pubTimestamp":1740501599,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日00时39分,Mural Oncology Plc股票出现波动,股价快速下跌5.18%。截至发稿,该股报3.66美元/股,成交量11.6134万股,换手率0.68%,振幅3.89%。Mural Oncology Plc股票所在的生物技术行业中,整体涨幅为0.01%。Mural Oncology Plc公司简介:Mural Oncology PLC 是一家临床阶段的肿瘤公司,其整个业务都集中在发现和开发可能有意义地改善癌症患者生活的免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022600395998926735&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022600395998926735&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MURA","BK4139"],"gpt_icon":0},{"id":"2513720664","title":"Mural Oncology Plc盘中异动 股价大跌5.19%报3.84美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513720664","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513720664?lang=zh_cn&edition=full","pubTime":"2025-02-24 23:02","pubTimestamp":1740409347,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日23时02分,Mural Oncology Plc股票出现波动,股价大幅下挫5.19%。截至发稿,该股报3.84美元/股,成交量4.4995万股,换手率0.26%,振幅7.90%。Mural Oncology Plc股票所在的生物技术行业中,整体涨幅为0.24%。Mural Oncology Plc公司简介:Mural Oncology PLC 是一家临床阶段的肿瘤公司,其整个业务都集中在发现和开发可能有意义地改善癌症患者生活的免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224230227962ea0aa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224230227962ea0aa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MURA"],"gpt_icon":0},{"id":"2510860660","title":"Mural Oncology Plc盘中异动 临近午盘股价大跌5.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510860660","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510860660?lang=zh_cn&edition=full","pubTime":"2025-02-11 00:49","pubTimestamp":1739206192,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日00时49分,Mural Oncology Plc股票出现异动,股价大幅下挫5.59%。截至发稿,该股报4.22美元/股,成交量10.369万股,换手率0.61%,振幅7.38%。Mural Oncology Plc股票所在的生物技术行业中,整体跌幅为0.08%。Mural Oncology Plc公司简介:Mural Oncology PLC 是一家临床阶段的肿瘤公司,其整个业务都集中在发现和开发可能有意义地改善癌症患者生活的免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211004952a240bf18&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211004952a240bf18&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MURA"],"gpt_icon":0},{"id":"2509628728","title":"Mural Oncology Plc盘中异动 急速上涨6.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509628728","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509628728?lang=zh_cn&edition=full","pubTime":"2025-02-07 23:33","pubTimestamp":1738942430,"startTime":"0","endTime":"0","summary":"北京时间2025年02月07日23时33分,Mural Oncology Plc股票出现异动,股价快速拉升6.07%。Mural Oncology Plc股票所在的生物技术行业中,整体跌幅为0.09%。Mural Oncology Plc公司简介:Mural Oncology PLC 是一家临床阶段的肿瘤公司,其整个业务都集中在发现和开发可能有意义地改善癌症患者生活的免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207233351a23d316c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207233351a23d316c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MURA","BK4139"],"gpt_icon":0},{"id":"2509820609","title":"Mural Oncology Plc盘中异动 临近午盘股价大涨5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509820609","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509820609?lang=zh_cn&edition=full","pubTime":"2025-02-07 00:31","pubTimestamp":1738859517,"startTime":"0","endTime":"0","summary":"北京时间2025年02月07日00时31分,Mural Oncology Plc股票出现异动,股价快速上涨5.14%。截至发稿,该股报4.28美元/股,成交量5.9532万股,换手率0.35%,振幅6.88%。Mural Oncology Plc股票所在的生物技术行业中,整体涨幅为0.20%。Mural Oncology Plc公司简介:Mural Oncology PLC 是一家临床阶段的肿瘤公司,其整个业务都集中在发现和开发可能有意义地改善癌症患者生活的免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207003157987ca161&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207003157987ca161&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MURA","BK4139"],"gpt_icon":0},{"id":"2509233888","title":"Mural Oncology Plc盘中异动 早盘急速拉升5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509233888","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509233888?lang=zh_cn&edition=full","pubTime":"2025-02-05 23:30","pubTimestamp":1738769436,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日23时30分,Mural Oncology Plc股票出现异动,股价大幅上涨5.15%。截至发稿,该股报3.88美元/股,成交量2.3734万股,换手率0.14%,振幅5.28%。Mural Oncology Plc股票所在的生物技术行业中,整体涨幅为1.29%。Mural Oncology Plc公司简介:Mural Oncology PLC 是一家临床阶段的肿瘤公司,其整个业务都集中在发现和开发可能有意义地改善癌症患者生活的免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205233036987b86fe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205233036987b86fe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MURA"],"gpt_icon":0},{"id":"2506137265","title":"Mural Oncology(MURA.US)获Jones Trading首次覆盖,给予买入评级, 目标价16.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2506137265","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506137265?lang=zh_cn&edition=full","pubTime":"2025-01-27 21:26","pubTimestamp":1737984401,"startTime":"0","endTime":"0","summary":"Mural Oncology(MURA.US)获Jones Trading首次覆盖,给予买入评级, 目标价16.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/27212647862182.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["MURA"],"gpt_icon":0},{"id":"2505772771","title":"Mural Oncology Plc盘中异动 早盘快速下挫5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505772771","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505772771?lang=zh_cn&edition=full","pubTime":"2025-01-22 23:46","pubTimestamp":1737560794,"startTime":"0","endTime":"0","summary":"北京时间2025年01月22日23时46分,Mural Oncology Plc股票出现波动,股价快速下挫5.07%。Mural Oncology Plc股票所在的生物技术行业中,整体涨幅为0.15%。Mural Oncology Plc公司简介:Mural Oncology PLC 是一家临床阶段的肿瘤公司,其整个业务都集中在发现和开发可能有意义地改善癌症患者生活的免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122234634986f8552&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122234634986f8552&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MURA","BK4139"],"gpt_icon":0},{"id":"2504520199","title":"Mural Oncology Plc盘中异动 股价大涨5.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2504520199","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2504520199?lang=zh_cn&edition=full","pubTime":"2025-01-18 00:40","pubTimestamp":1737132031,"startTime":"0","endTime":"0","summary":"北京时间2025年01月18日00时40分,Mural Oncology Plc股票出现异动,股价大幅拉升5.42%。截至发稿,该股报3.89美元/股,成交量3.6351万股,换手率0.21%,振幅4.34%。Mural Oncology Plc股票所在的生物技术行业中,整体涨幅为0.60%。Mural Oncology Plc公司简介:Mural Oncology PLC 是一家临床阶段的肿瘤公司,其整个业务都集中在发现和开发可能有意义地改善癌症患者生活的免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250118004032a225d9b5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250118004032a225d9b5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MURA"],"gpt_icon":0},{"id":"2502867227","title":"Mural Oncology Plc盘中异动 急速上涨5.89%报3.87美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2502867227","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2502867227?lang=zh_cn&edition=full","pubTime":"2025-01-10 22:31","pubTimestamp":1736519489,"startTime":"0","endTime":"0","summary":"北京时间2025年01月10日22时31分,Mural Oncology Plc股票出现异动,股价急速拉升5.89%。截至发稿,该股报3.87美元/股,成交量8.7387万股,换手率0.51%,振幅0.96%。Mural Oncology Plc股票所在的生物技术行业中,整体跌幅为0.32%。Mural Oncology Plc公司简介:Mural Oncology PLC 是一家临床阶段的肿瘤公司,其整个业务都集中在发现和开发可能有意义地改善癌症患者生活的免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250110223130aba60259&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250110223130aba60259&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MURA"],"gpt_icon":0},{"id":"2502770924","title":"Mural Oncology Plc盘中异动 股价大涨5.33%报3.66美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2502770924","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2502770924?lang=zh_cn&edition=full","pubTime":"2025-01-09 00:37","pubTimestamp":1736354271,"startTime":"0","endTime":"0","summary":"北京时间2025年01月09日00时37分,Mural Oncology Plc股票出现异动,股价大幅上涨5.33%。截至发稿,该股报3.66美元/股,成交量12.1811万股,换手率0.71%,振幅3.75%。Mural Oncology Plc股票所在的生物技术行业中,整体涨幅为0.52%。Mural Oncology Plc公司简介:Mural Oncology PLC 是一家临床阶段的肿瘤公司,其整个业务都集中在发现和开发可能有意义地改善癌症患者生活的免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250109003751985f8ef7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250109003751985f8ef7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MURA","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.muraloncology.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":-0.0192},{"period":"3month","weight":-0.0192},{"period":"6month","weight":-0.1707},{"period":"1year","weight":-0.4545},{"period":"ytd","weight":-0.3665}],"compareEarnings":[{"period":"1week","weight":-0.0057},{"period":"1month","weight":-0.0024},{"period":"3month","weight":0.037},{"period":"6month","weight":0.142},{"period":"1year","weight":0.1281},{"period":"ytd","weight":0.1633}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Mural Oncology plc是一家爱尔兰注册公众有限公司,于2017年5月成立,是一家私人股份有限公司,2023年8月21日,该公司重新注册为公共有限公司,并更名为Mural Oncology plc。该公司是一家临床阶段的肿瘤学公司,专注于发现和开发可能有意义地改善癌症患者生活的免疫疗法。通过利用公司在免疫细胞调节和蛋白质工程方面的核心竞争力,该公司开发了一系列新型的研究性细胞因子疗法,旨在解决多种癌症患者未满足需求的领域。该公司的主要候选产品nemvaleukin alfa(“nemvaleukin”)是一种研究性、工程化的白细胞介素-2(“IL-2”)细胞因子,旨在捕获和扩大大剂量重组人IL-2(“rhIL-2”)的治疗益处,同时减轻其标志性毒性。","exchange":"NASDAQ","name":"Mural Oncology","nameEN":"Mural Oncology"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Mural Oncology(MURA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Mural Oncology(MURA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Mural Oncology,MURA,Mural Oncology股票,Mural Oncology股票老虎,Mural Oncology股票老虎国际,Mural Oncology行情,Mural Oncology股票行情,Mural Oncology股价,Mural Oncology股市,Mural Oncology股票价格,Mural Oncology股票交易,Mural Oncology股票购买,Mural Oncology股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Mural Oncology(MURA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Mural Oncology(MURA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}